Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Ureteral Stent Symptoms
NCT06930690Phase 2Recruiting
- Sponsor
- Houston Methodist Research Institute
- Start
- Jun 2026
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in ureteral stent-related symptoms (USRS), sponsored by Houston Methodist Research Institute. Started Jun 2026; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
ureteral stent-related symptoms (USRS)
Beyond the preview
Go deeper on NCT06930690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06930690.